Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Stem Cells For COVID-19: Promising Platform With A ‘Dark Side’

Jul 21 2020

• By Bridget Silverman

Stem Cells, 3D rendering. - Illustration

Related Content

FDA Ups Pressure On Stem Cell Therapy Makers To Follow Product Approval Rules

Jan 03 2019

World Regulators Wrestle With Advanced Therapies

Oct 08 2018

Mesoblast, Athersys Take Lead In Race To Develop Stem Cell Therapies For COVID-19

Jul 21 2020

Can US FDA Regulate Stem Cell Transplantation? Court Says Question Must Go To Trial

Feb 07 2020

Cell Therapies: US FDA Asked To Clarify Development Standards For Early-Phase Trials

May 22 2019

Related Companies

Mesoblast Limited

Athersys, Inc.

Additional Topics

United States Regenerative Medicine Coronavirus COVID-19 Drug Approval Standards Regulation Infectious Diseases BioPharmaceutical

More from Cell & Gene Therapies

More from Advanced Technologies

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window